Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test product
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Rosacea
Conditions
Rosacea
Trial Timeline
Dec 12, 2017 → Sep 28, 2018
NCT ID
NCT03689010About Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test product
Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test product is a phase 1 stage product being developed by Sun Pharmaceutical for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT03689010. Target conditions include Rosacea.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03689010 | Phase 1 | Completed |
Competing Products
20 competing products in Rosacea
Other Products from Sun Pharmaceutical
Ilumya Injectable ProductApproved
85
CequaTM (Cyclosporine 0.09%) ophthalmic solutionApproved
85
Cyclosporine + Artificial tearApproved
85
AmifostineApproved
85
Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapyApproved
85